The growing field of immunotherapy relies heavily on recombinant mediator technology, and a precise understanding of individual profiles is paramount for fine-tuning experimental design and therapeutic efficacy. https://social40.com/story6477080/understanding-recombinant-cytokine-profiles-il-1a-il-1b-il-2-and-il-3